Categories Earnings, Retail

Monster Beverage drops after Q2 earnings and sales missed estimates

Monster Beverage (NASDAQ: MNST) stock fell about 6% in the extended trading session as the company missed earnings and sales estimates for the second quarter 2019. The company’s profit for the second quarter of $0.53 per share and revenue of $1.10 billion failed to meet the market’s earnings projection of $0.56 per share and estimated revenue of $1.13 billion.

Monster Beverage (MNST) drops after Q2 earnings and sales missed estimates

“We are pleased to report record gross and net sales in the 2019 second quarter, driven by our Reign Total Body Fuel high performance energy drinks, which we launched in the first quarter, as well as growth in our Monster Energy brand energy drinks both domestically and internationally,” said CEO Rodney Sacks.

Related: Coca-Cola tops Q2 estimates and lifts outlook

“Our Monster Energy brand energy drinks were launched in a number of new countries during the quarter in the Middle East, Latin America and the Caribbean. Later this year we are planning to introduce a number of new Monster Energy brand energy drinks in the United States and in various international markets,” Sacks added.

Also read: PepsiCo edges past market estimates in Q2

In July, beverage giants PepsiCo (NASDAQ: PEP) and Coca-Cola (NYSE: KO) reported their second quarter results. Both the companies surpassed the market’s earnings estimates for their recently ended quarter.

Monster Beverage stock had advanced 23% since the beginning of this year and inched up 1% in the trailing 12 months.

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top